Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2011 1
2014 4
2015 4
2016 5
2017 5
2018 3
2019 4
2021 2
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, van Rooij N, van Leerdam ME, Depla A, Smit EF, Hartemink KJ, de Groot R, Wolkers MC, Sachs N, Snaebjornsson P, Monkhorst K, Haanen J, Clevers H, Schumacher TN, Voest EE. Dijkstra KK, et al. Among authors: van der velden dl. Cell. 2018 Sep 6;174(6):1586-1598.e12. doi: 10.1016/j.cell.2018.07.009. Epub 2018 Aug 9. Cell. 2018. PMID: 30100188 Free PMC article.
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, Schipper L, Hoes L, Vis DJ, van de Haar J, Prevoo W, Snaebjornsson P, van der Velden D, Klein M, Chalabi M, Boot H, van Leerdam M, Bloemendal HJ, Beerepoot LV, Wessels L, Cuppen E, Clevers H, Voest EE. Ooft SN, et al. Among authors: van der velden d. Sci Transl Med. 2019 Oct 9;11(513):eaay2574. doi: 10.1126/scitranslmed.aay2574. Sci Transl Med. 2019. PMID: 31597751
TAS-102 and the quest for predictive biomarkers.
van der Velden DL, Opdam FL, Opdam FL. van der Velden DL, et al. ESMO Open. 2017 Sep 21;2(4):e000263. doi: 10.1136/esmoopen-2017-000263. eCollection 2017. ESMO Open. 2017. PMID: 29018579 Free PMC article. No abstract available.
Mast cells in rheumatic disease.
Suurmond J, van der Velden D, Kuiper J, Bot I, Toes RE. Suurmond J, et al. Among authors: van der velden d. Eur J Pharmacol. 2016 May 5;778:116-24. doi: 10.1016/j.ejphar.2015.03.085. Epub 2015 May 2. Eur J Pharmacol. 2016. PMID: 25943290 Review.
Prognostic value of CT characteristics in GEP-NET: A systematic review.
van der Velden DL, Staal FCR, Aalbersberg EA, Castagnoli F, Wilthagen E, Beets-Tan RGH. van der Velden DL, et al. Crit Rev Oncol Hematol. 2022 Jul;175:103713. doi: 10.1016/j.critrevonc.2022.103713. Epub 2022 May 20. Crit Rev Oncol Hematol. 2022. PMID: 35598829 Review.
GEP-NET radiomics: a systematic review and radiomics quality score assessment.
Staal FCR, Aalbersberg EA, van der Velden D, Wilthagen EA, Tesselaar MET, Beets-Tan RGH, Maas M. Staal FCR, et al. Among authors: van der velden d. Eur Radiol. 2022 Oct;32(10):7278-7294. doi: 10.1007/s00330-022-08996-w. Epub 2022 Jul 26. Eur Radiol. 2022. PMID: 35882634 Review.
Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.
van Waalwijk van Doorn-Khosrovani SB, Pisters-van Roy A, van Saase L, van der Graaff M, Gijzen J, Sleijfer S, Hoes LR, van Berge Henegouwen JM, van der Wijngaart H, van der Velden DL, van Werkhoven E, Retel VP, van Harten WH, Huitema ADR, Timmers L, Gelderblom H, Verheul HMW, Voest EE. van Waalwijk van Doorn-Khosrovani SB, et al. Among authors: van der velden dl. Ann Oncol. 2019 May 1;30(5):663-665. doi: 10.1093/annonc/mdz119. Ann Oncol. 2019. PMID: 31038154 Free article. No abstract available.
32 results